Dimerization of MLL fusion proteins immortalizes hematopoietic cells

Cancer Cell

Volumn 4, Issue 3, 2003, Pages 197-207

  Martin, Mary Ellen ^a   Milne, Thomas A ^a,b   Bloyer, Sebastien ^b   Galoian, Karine ^a   Shen, Weiping ^a   Gibbs, Denise ^a   Brock, Hugh W ^b   Slany, Robert ^c   Hess, Jay L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; HYBRID PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN;

ARTICLE; BINDING AFFINITY; BONE MARROW; BONE MARROW CELL; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CPG ISLAND; DIMERIZATION; DNA BINDING; EXON; GENE CONTROL; GENE DUPLICATION; GENE FUNCTION; GENE LOCUS; GENETIC TRANSCRIPTION; GENETIC TRANSFORMATION; HEMATOPOIETIC CELL; HOX GENE; LEUKEMOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 0141680407     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00214-9     Document Type: Article

References (63)

1. Akashi K., He X., Chen J., Iwasaki H., Niu C., Steenhard B., Zhang J., Haug J., Li L. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood. 101:2003;383-389.
2. Amara J.F., Clackson T., Rivera V.M., Guo T., Keenan T., Natesan S., Pollock R., Yang W., Courage N.L., Holt D.A., Gilman M. A versatile synthetic dimerizer for the regulation of protein-protein interactions. Proc. Natl. Acad. Sci. USA. 94:1997;10618-10623.
3. Appel S.H., Alpers D.H., Tomkins G.M. Multiple molecular forms of β-galactosidase. J. Mol. Biol. 11:1965;12-22.
4. Armstrong S.A., Staunton J.E., Silverman L.B., Pieters R., den Boer M.L., Minden M.D., Sallan S.E., Lander E.S., Golub T.R., Korsmeyer S.J. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. 30:2002;41-47.
5. Ayton P.M., Cleary M.L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 20:2001;5695-5707.
6. Birke M., Schreiner S., Garcia-Cuellar M.-P., Mahr K., Titgemeyer F., Slany R.K. The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation. Nucleic Acids Res. 30:2002;958-965.
7. Bourachot B., Yaniv M., Muchardt C. The activity of mammalian brm/SNF2α is dependent on a high-mobility-group protein I/Y-like DNA binding domain. Mol. Cell. Biol. 19:1999;3931-3939.
8. Buske C., Humphries R.K. Homeobox genes in leukemogenesis. Int. J. Hematol. 71:2000;301-308.
9. Caligiuri M.A., Strout M.P., Lawrence D., Arthur D.C., Baer M.R., Yu F., Knuutila S., Mrozek K., Oberkircher A.R., Marcucci G.et al. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res. 58:1998;55-59.
10. Chaplin T., Bernard O., Beverloo H.B., Saha V., Hagemeijer A., Berger R., Young B.D. The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. Blood. 86:1995;2073-2076.
11. Chervinsky D.S., Sait S.N., Nowak N.J., Shows T.B., Aplan P.D. Complex MLL rearrangement in a patient with T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer. 14:1995;76-84.
12. DiMartino J.F., Cleary M.L. MLL rearrangements in haematological malignancies. lessons learned from clinical and biological studies Brit. J. Haem. 106:1999;614-626.
13. DiMartino J.F., Ayton P.M., Chen E.H., Naftzger C.C., Young B.D., Cleary M.L. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood. 99:2002;3780-3785.
14. Dobson C.L., Warren A.J., Pannell R., Forster A., Rabbits T.H. Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene. EMBO J. 19:1999;843-851.
15. Dohner K., Tobis K., Ulrich R., Frohling S., Benner A., Schlenk R.F., Dohner H. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics. a study of the Acute Myeloid Leukemia Study Group Ulm J. Clin. Oncol. 20:2002;3254-3261.
16. Downing J.R., Look A.T. MLL fusion genes in the 11q23 leukemias. Cancer Treat. Res. 84:1996;73-92.
17. Drabkin H.A., Parsy C., Ferguson K., Guilhot F., Lacotte L., Roy L., Zeng C., Baron A., Hunger S.P., Varella-Garcia M.et al. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. Leukemia. 16:2002;186-195.
18. Ernst P., Wang J., Huang M., Goodman R.H., Korsmeyer S.J. MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein. Mol. Cell. Biol. 21:2001;2249-2258.
19. Fair K., Anderson M., Bulanova E., Mi H., Tropschug M., Diaz M.O. Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells. Mol. Cell. Biol. 21:2001;3589-3597.
20. Frank S.R., Schroeder M., Fernandez P., Taubert S., Amati B. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 15:2001;2069-2082.
21. Fujino T., Yamazaki Y., Largaespada D.A., Jenkins N.A., Copeland N.G., Hirokawa K., Nakamura T. Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Exp. Hematol. 29:2001;856-863.
22. Galoian K., Milne T., Brock H., Shilatifard A., Slany R., Hess J.L. Deregulation of c-myc by leukemogenic MLL fusion proteins. Blood Suppl. 96:2000;457a.
23. Hawley R.G., Lieu F.H.L., Fong A.Z.C., Hawley T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:1994;136-138.
24. Hess J.L., Yu B.D., Li B., Hanson R., Korsmeyer S.J. Defects in yolk sac hematopoiesis in Mll-null embryos. Blood. 90:1997;1799-1806.
25. Hsieh J.J., Ernst P., Erdjument-Bromage H., Tempst P., Korsmeyer S.J. Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization. Mol. Cell. Biol. 23:2003;186-194.
26. Jacobson R.H., Zhang X.J., DuBose R.F., Matthews B.W. Three-dimensional structure of beta-galactosidase from E. coli. Nature. 369:1994;761-766.
27. Kawagoe H., Humphries R.K., Blair A., Sutherland H.J., Hogge D.E. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia. 13:1999;687-698.
28. Kroon E., Krosl J., Thorsteinsdottir U., Baban S., Buchberg A.M., Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 17:1998;3714-3725.
29. Lavau C., Szilvassy S.J., Slany R., Cleary M.L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16:1997;4226-4237.
30. Lavau C., Du C., Thirman M., Zeleznik-Le N. Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia. EMBO J. 17:2000;4655-4664.
31. Li J., Shen H., Himmel K.L., Dupuy A.J., Largaespada D.A., Nakamura T., Shaughnessy J.D. Jr., Jenkins N.A., Copeland N.G. Leukaemia disease genes. large-scale cloning and pathway predictions Nat. Genet. 23:1999;348-353.
32. Linder B., Newman R., Jones L.K., Debernardi S., Young B.D., Freemont P., Verrijzer C.P., Saha V. Biochemical analyses of the AF10 protein. the extended LAP/PHD-finger mediates oligomerisation J. Mol. Biol. 299:2000;369-378.
33. Milne T.A., Briggs S.D., Brock H.W., Martin M.E., Gibbs D., Allis C.D., Hess J.L. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell. 10:2002;1107-1117.
34. Moskow J.J., Bullrich F., Huebner K., Daar I.O., Buchberg A.M. Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice. Mol. Cell. Biol. 10:1995;5434-5443.
35. Nakamura T., Largaespada D.A., Shaughnessy J.D. Jr., Jenkins N.A., Copeland N.G. Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias. Nat. Genet. 12:1996;149-153.
36. Nakamura T., Mori T., Tada S., Krajewski W., Rozovskaia T., Wassell R., Dubois G., Mazo A., Croce C.M., Canaani E. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell. 10:2002;1119-1128.
37. Nie Z., Yan Z., Chen E.H., Sechi S., Ling C., Zhou S., Xue Y., Yang D., Murray D., Kanakubo E.et al. Novel SWI/SNF chromatin- remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner. Mol. Cell. Biol. 23:2003;2942-2952.
38. Ono R., Taki T., Taketani T., Taniwaki M., Kobayasji H., Hayashi Y. LCX, leukemia-associated protein with a CXXC domain is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res. 62:2002;4075-4080.
39. Orlando V. Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends Biochem. Sci. 25:2000;99-104.
40. Park I.K., He Y., Lin F., Laerum O.D., Tian Q., Bumgarner R., Klug C.A., Li K., Kuhr C., Doyle M.J.et al. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood. 99:2002;488-498.
41. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:1993;8392-8396.
42. Pegram L.D., Megonigal M.D., Lange B.J., Nowell P.C., Rowley J.D., Rappaport E.F., Felix C.A. 3;11) translocation in treatment-related acute myeloid leukemia fuses MLL with the GMPS (GUANOSINE 5′ MONOPHOSPHATE SYNTHETASE) gene. Blood. 96:2000;4360-4362.
43. Pineault N., Helgason C.D., Lawrence H.J., Humphries R.K. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp. Hematol. 30:2002;49-57.
44. Prasad R., Leshkowits D., Gu Y., Adler H., Nakamura T., Saito H., Heubner K., Berger R., Croce C.M., Canaani E. Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia. Proc. Natl. Acad. Sci. USA. 91:1994;8107-8111.
45. Rozenblatt-Rosen O., Rozovskaia T., Burakov D., Sedkov Y., Tillib S., Blechman J., Nakamura T., Croce C.M., Mazo A., Canaani E. The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc. Natl. Acad. Sci. USA. 95:1998;4152-4157.
46. Rozovskaia T., Rozenblatt-Rosen O., Sedkov Y., Burakov D., Yano T., Nakamura T., Petruck S., Ben-Simchon L., Croce C.M., Mazo A., Canaani E. Self-association of the SET domains of human ALL-1 and of Drosophila TRITHORAX and ASH1 proteins. Oncogene. 19:2000;351-357.
47. Rozovskaia T., Feinstein E., Mor O., Foa R., Blechman J., Nakamura T., Croce C.M., Cimino G., Canaani E. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4: 11) abnormality. Oncogene. 20:2001;874-878.
48. Sano K. Structure of AF3p21, a new member of mixed lineage leukemia (MLL) fusion partner proteins- implication for MLL-induced leukemogenesis. Leuk. Lymph. 42:2001;595-602.
49. Schreiner S.A., Garcia-Cuellar M.P., Fey G.H., Slany R.K. The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator. Leukemia. 13:1999;1525-1533.
50. Schreiner S., Birke M., Garcia-Cuellar M.P., Zilles O., Greil J., Slany R.K. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation. Cancer Res. 61:2001;6480-6486.
51. Schultz D.C., Friedman J.R., Rauscher F.J. III. Targeting histone deacetylase complexes via KRAB-zinc finger proteins. the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2 subunit of NuRD Genes Dev. 15:2001;428-443.
52. Slater D.J., Hilgenfeld E., Rappaport E.F., Shah N., Meek R.G., Williams W.R., Lovett B.D., Osheroff N., Autar R.S., Ried T., Felix C.A. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site. Oncogene. 21:2002;4706-4714.
53. So C.W., Cleary M.L. Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood. 101:2003;633-639.
54. Sorensen P.H., Chen C.S., Smith F.O., Arthur D.C., Domer P.H., Bernstein I.D., Korsmeyer S.J., Hammond G.D., Kersey J.H. Molecular rearrangements of the MLL gene are present in most cases of acute infant myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J. Clin. Inv. 93:1994;429-437.
55. Strehl S., Borkhardt A., Slany R., Fuchs U., Konig M., Haas O.A. The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11:17)(q23;q21). Oncogene. 22:2003;157-160.
56. Thorsteinsdottir U., Kroon E., Jerome L., Blasi F., Sauvageau G. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol. Cell. Biol. 21:2001;224-234.
57. Thorsteinsdottir U., Mamo A., Kroon E., Jerome L., Bijl J., Lawrence H.J., Humphries K., Sauvageau G. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood. 99:2002;121-129.
58. Wehrman T., Kleaveland B., Her J.-H., Balint R.F., Blau H.M. Protein-protein interactions monitored in mammalian cells via complementation of β-lactamase enzyme fragments. Proc. Natl. Acad. Sci. USA. 99:2002;3469-3474.
59. Yeoh E.J., Ross M.E., Shurtleff S.A., Williams W.K., Patel D., Mahfouz R., Behm F.G., Raimondi S.C., Relling M.V., Patel A.et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 1:2002;133-143.
60. Yokoyama A., Kitabayashi I., Ayton P.M., Cleary M.L., Ohki M. Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood. 100:2002;3710-3718.
61. Yu B.D., Hess J.L., Horning S.E., Brown G.A., Korsmeyer S.J. Altered Hox expression and segmental identity in Mll-mutant mice. Nature. 378:1995;505-508.
62. Yu B.D., Hanson R.D., Hess J.L., Horning S.E., Korsmeyer S.J. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis. Proc. Natl. Acad. Sci. USA. 95:1998;10632-10636.
63. Zeisig B.B., Schreiner S., Garcia-Cuellar M.-P., Slany R.K. Transcriptional activation is a key function encoded by MLL fusion partners. Leukemia. 17:2003;359-365.